Abstract:Mouse embryonic stem cells (ESCs) are derived from the inner cell mass of mouse blastocysts. Mouse ESCs are pluripotent and contribute widely to the formation of the three embryonic germ layers in chimeric mice but not to that of the extra-embryonic trophectoderm. A small population of transient cells (less than 1%) has been identified occasionally in the culture of mouse ESCs, which has been shown to exhibit a gene expression profile similar to that of cells in 2-cell stage embryos (2C-like cells). 2C-like cells were found to be generated spontaneously from mouse ESCs and induced pluripotent stem cells (iPSCs) when they were cultured in the serum-supplemented with leukemia inhibitory factor (LIF) on feeder cells in vitro. 2C-like cells have been considered to be totipotent. There is evidence suggesting that 2C-like cells can effectively generate both embryonic and extra-embryonic tissues, and therefore, 2C-like cells can be potentially used as a model for in vitro totipotent stem cell research. However, only a small population of ESCs could transit to 2C-like state in the serum-containing culture medium. There are several 2C specific genes that express when ESCs enter 2C-like state, such as Zscan4, Mervl, Dux, Nelfa, Tdpoz1/2/4 and Tcstv1/3. Notably, 2C-like cells exhibit highly relaxed chromatin architecture, which is similar to that observed in 2-cell stage embryos. Genome-wide demethylation occurs upon transition of mouse ESCs into 2C-like state, including gene bodies, promoters, and repeat elements. The dynamics of the reprogramming process from ESCs to 2C-like cells are still unclear, which have certainly uncovered an intricate regulatory mechanism mediated by specific genes, proteins, as well as some metabolites and non-coding RNAs. Additionally, one of the important features of totipotency is that a single cell can form an entire organism. Therefore, totipotent stem cells form a valuable tool to study the early developmental processes in vitro and prove to be beneficial for regenerative medicine applications. For instance, the embryonic stem cells have been used to generate embryo-like structures. The artificial embryo-like structures not only facilitate the studies on the key events in early embryonic development, but also serve as a model for investigating the early developmental defects occurring in humans. Several previous studies revealed that ESCs at different totipotent states can arise in in vitro cultures, and they focused on identifying culture conditions that induce 2C-like states. For example, knockout serum replacement (KOSR) media promotes the induction of 2C-like cells from ESCs in in vitro culture, as indicated by the increased levels of ZSCAN4-positive cells. Additionally, the suppression of glycolysis mediated by 2-deoxy-d-glucose (2-DG) in serum plus LIF condition induces the 2C transcriptional programming in ESCs. Interestingly, the most recent research indicates that the spliceosomal repression in mouse ESCs drives the pluripotent-to-totipotent state transition. Using the splicing inhibitor pladienolide B, they achieved stable in vitro culture of totipotent ESCs comparable at the molecular levels with 2- and 4-cell blastomeres. In our recent study, we also demonstrated that retinoic acid induces NELFA-mediated 2C-like state of mouse embryonic stem cells, which is associated with epigenetic modifications and metabolic processes in chemically defined media. Here, we review the discovery, molecular regulatory mechanism, chromatin characteristics, activation strategies, and the relationship of 2C-like cells with somatic reprogramming.

Acquisition of 2C-like totipotency through defined maternal-effect factors

Derivation of totipotent-like stem cells with blastocyst-like structure forming potential

Generation and characterization of mouse parthenogenetic embryonic stem cells containing genomes from non-growing and fully grown oocytes.

Induction of mouse totipotent stem cells by a defined chemical cocktail

Review on 2C-Like State of Mouse Embryonic Stem Cells

Totipotency of mouse zygotes extends to single blastomeres of embryos at the four-cell stage

2-Cell-like Cells: an Avenue for Improving SCNT Efficiency

A CRISPR/Cas9 screen in embryonic stem cells reveals that Mdm2 regulates totipotency exit

Epigenetic reprogramming in the transition from pluripotency to totipotency

Capture of Totipotency in Mouse Embryonic Stem Cells in the Absence of Pdzk1

Comparative Analyses of Single-Cell Transcriptomic Profiles between In Vitro Totipotent Blastomere-like Cells and In Vivo Early Mouse Embryonic Cells

Zfp281 Inhibits the Pluripotent-to-Totipotent State Transition in Mouse Embryonic Stem Cells

Rolling back human pluripotent stem cells to an eight-cell embryo-like stage

Timely stimulation of early embryo promotes the acquisition of pluripotency

In Vitro Generation of Mouse Morula-Like Cells.

Rolling back of human pluripotent stem cells to an 8-cell embryo-like stage

The Four Reprogramming Factors and Embryonic Development in Mice

Oocyte-Associated Transcription Factors In Reprogramming After Somatic Cell Nuclear Transfer: A Review

The totipotent 2C‐like state safeguards genomic stability of mouse embryonic stem cells

Chromatin structure in totipotent mouse early preimplantation embryos

Remodeling of H3K9me3 During the Pluripotent to Totipotent-Like State Transition